# OnCo record obecabtagene-autoleucel (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/obecabtagene-autoleucel/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "obecabtagene-autoleucel" ;
  schema:name "Obecabtagene autoleucel"@en ;
  schema:description "A CD19 CAR-T built to grip and release quickly, which cut severe side effects and gave adults with relapsed ALL a real chance at durable remission."@en ;
  schema:url <https://onco.cc/drugs/obecabtagene-autoleucel/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Obecabtagene%20autoleucel> ;
  onco:status "approved" ;
  onco:modality "CAR-T (CD19, fast off-rate)" ;
  schema:alternateName "Aucatzyl" ;
  onco:approval "US 2024: Relapsed or refractory B-cell precursor ALL, adults", "EU 2025: Relapsed or refractory B-ALL, adults ≥26 years" ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/cd19/> ;
  onco:companies <https://onco.cc/companies/autolus/> ;
  onco:terms <https://onco.cc/terms/crs/>, <https://onco.cc/terms/icans/> ;
  onco:trials <https://onco.cc/trials/felix/> .